EANS-News: november Aktiengesellschaft / Balanced Result And Especially Successful Operating Business Result

• Overall result of the group nearly break-even
• Significant cost reduction
• Liabilities reduced further
• Surpluses in HGB separate financial statements
• Increase in adjusted sales revenues
• Significant increase in gross margin
• Significantly improved margin

--------------------------------------------------------------------------------
Corporate news transmitted by euro adhoc. The issuer/originator is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------

annual result/Publication of annual report 2010

Subtitle: • Overall result of the group nearly break-even
• Significant cost reduction
• Liabilities reduced further
• Surpluses in HGB separate financial statements
• Increase in adjusted sales revenues
• Significant increase in gross margin
• Significantly improved margin

Cologne (euro adhoc) - Today, March 31, 2011, november AG, Cologne,
listed in the Prime Standard of the German Stock Exchange (Deutsche
Börse) is publishing its annual financial statements for 2010.

In 2010, november AG again achieved an almost break-even result of
EUR -295 thousand (2009: EUR -323 thousand) despite consolidated
sales that fell significantly by EUR 1,173 thousand to EUR 4,078
thousand (2009: EUR 5,251 thousand). This sales decline as compared
to 2009 resulted from the termination of the distribution business of
the AXIS-SHIELD product line at november´s affiliated company PROGEN
Biotechnik GmbH. An improved margin and a considerable cost reduction
secured the consolidated result. It was also possible to almost halve
the Group's total liability from EUR 7,501 thousand (2009) to EUR
4,113 thousand. Further waivers worth EUR 1,451 thousand were already
granted in January 2011. In 2010, the HGB financial statements and
consequently tax-relevant results of the major companies showed a
surplus in the operating result of november AG of EUR 904 thousand
(2009: EUR 1,156 thousand), of PROGEN Biotechnik GmbH of EUR 875
thousand (2009: EUR 839 thousand) and of MULTIMETRIX GmbH of EUR 667
thousand (2009: EUR 697 thousand). These results are mainly a result
of extraordinary income. It is expected that it will be possible to
employ loss carryforwards in full for tax-reducing purposes.

At the most important operative affiliated company PROGEN Biotechnik
GmbH, sales turnover decreased considerably by EUR 861 thousand to
EUR 4,238 thousand (2009: EUR 5,099 thousand) due to the termination
of the AXIS-Shield product line in 2009. The adjusted comparison of
sales turnovers, i.e. annual comparison without the AXIS-Shield
turnover, shows a significant increase in sales of 11.4% with the
remaining products and services. Despite the fact that the total
turnover as compared to 2009 decreased considerably by 16.9%, the
gross profit in 2010 increased by a remarkable 42.4% from EUR 2,026
thousand (2009) to its current level of EUR 2,886 thousand. As total
costs for 2009 and 2010 almost remained constant, PROGEN was in a
position to completely compensate in 2010 the termination of the
AXIS-Shield business in 2009. Overall, these developments have had a
clearly positive impact on the total consolidated results.

A further important area of potential growth for PROGEN worldwide is
the takeover of employees from Microbionix GmbH and the already
published takeover of the distribution of Asuragen products and
PATHFAST products of MITSUBISHI.

For the entire annual report 2010, please refer to
http://www.november.eu/company-profile/reports/

end of announcement euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: november Aktiengesellschaft
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Dr. Dirk Zurek
Vorstand/CEO
Tel.: +49 (0) 221 82200 520 10
E-Mail: ir@november.de

Branche: Biotechnology
ISIN: DE000A0Z24E9
WKN: A0Z24E
Index: CDAX, Prime All Share, Technology All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Stuttgart / free trade
Düsseldorf / free trade
Hannover / free trade
München / free trade